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EDITORIAL
In this issue, Kay et al1 report the first documented case
of new variant Creutzfeldt-Jakob disease (nvCJD) in
Hong Kong. The emergence in 1987 of bovine spongi-
form encephalopathy (BSE) in British cattle2 followed
by the first case of human nvCJD3 in 1996 ushered
in political, economic, and social turbulence that
exceeded the absolute amount of morbidity and mortal-
ity. Current epidemiological evidence suggests that
this case of nvCJD is imported from the United
Kingdom, where nvCJD and BSE are endemic. While
such cases might seem remote to most local practition-
ers, this timely episode calls for a reflection on emer-
ging infectious diseases by all medical professionals
in Hong Kong.
From an epidemiological viewpoint, the appearance
and reappearance of infectious diseases is closely tied
to increases in population density, changes in human
behaviour and environmental conditions, which are
often closely intertwined. For example, global warming
and climatic changes (eg El Niño and La Niña) have
profound effects on the epidemiology of infectious
diseases: changes in the population and distribution
of vectors for transmission (eg mosquitoes and Dengue
fever, malaria); changes in the population of natural
reservoir hosts (eg rodents and hantaviruses, arbo-
viruses, and Leptospira); and droughts and floods
(eg cholera and other enteric infections). It is estimated
that by the end of this century, global warming will
enlarge the zone of potential malaria transmission from
an area containing 45% of the world’s population to
an area containing about 60%.4 Major climatic changes
not only have an impact on the zooepidemiology of
vectors and infective agents, but the accompanying
natural disasters will almost always have a negative
public health impact on societies.
Unlike environmental changes, human behaviour
is theoretically more amenable to interventions.
Behavioural contributions to the epidemiology of
infectious diseases can be seen in: sexually transmitted
diseases and the AIDS pandemic as a result of the
commercial sex trade; enteric infections and outbreaks
as a result of improper food handling and consumption
habits; zoonotic infections as a result of deforestation
and destruction of the natural environment; and
acquisition of exotic infections as a result of increasing
ease of international travel. In contrast with other
metropolitan areas, where zoonotic infections usually
occur as a result of occupational or recreational
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exposure to animals, our unique cultural and religious
preference for live poultry results in a significant pro-
portion of the local population being exposed to avian
pathogens—most notably the avian influenza viruses—
within walking distance in the retail markets. Political
conflicts, warfare, and poverty also provide the perfect
spawning ground for diseases such as epidemic typhus
and trench fever. Yet, history proves that human behav-
iour often acts in favour of propagation rather than
control of infections.
Hong Kong has been in the infectious diseases
spotlight on at least three previous occasions. In 1894,
a plague epidemic swept Hong Kong and southern
China and started the last plague pandemic5 in which
more than 20 million people died worldwide. In the
same year, Alexandre Yersin of the Institut Pasteur
discovered the bacterium in a Hong Kong Chinese
patient dying of plague; this was subsequently named
Yersinia pestis. In 1969, a new strain of influenza
(H3N2 virus—the ‘Hong Kong flu’) emerged here,
heralding the first H3N2 pandemic in recent times and,
to this day, replacing the H2N2 virus. In the United States
alone, the H3N2 pandemic resulted in an influenza-
associated mortality count of at least 33 800.6 In 1997,
the outbreak of avian influenza H5N1 infection again
shocked the world, with 18 proven human cases and
six fatalities.7 Significant economic losses were also
noted in association with this outbreak. Less shocking,
although equally devastating to the local communities
affected, are outbreaks of cholera of which the largest
outbreak occurred during the severe water shortage
years of 1963 and 1964. To date, two of these three
common pandemic pathogens, influenza and cholera
remain major public health problems in our locality.
Do all these mean that Hong Kong is particularly
incompetent in public health management? Defin-
itely not; indeed, the opposite is probably true. Com-
pared with other parts of the world, the health care
infrastructure in Hong Kong is fairly sophisticated,
including provision of safe food and water, sewage
disposal, comprehensive immunisation programmes,
accessibility to and quality of health care services, and
excellent public health surveillance. The infectious
diseases that have plagued Hong Kong probably
originated in our neighbourhood. However, the unique
and strategic position of Hong Kong in regional and
international traffic, together with the quality of our
infrastructure, has enabled us to be the first ones to
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detect and react to the emergence of new infections
which might have gone unnoticed at their point of
origin. There are suggestions for an ostrich-like
approach to infectious disease surveillence. This,
however, must be vehemently resisted: the later an
emerging infection is detected, the more difficult it
will be to control it, and the more damage it will incur
on society’s stability and international image, as well
as the administration’s authority.
With the constant threat of emerging and re-
emerging infections, our time-tested armamentarium
against infectious diseases—antimicrobial agents and
vaccines—may not be as useful in the future as it was
in the past. New forms of antimicrobial resistance
appear rapidly in microbes as a result of natural mu-
tations and improper use of antimicrobial agents.8-11
Indeed, this is now considered as one form of emerging
infection. Despite major advances in the development
of new drugs, we are still faced with a large group of
pathogens for which no effective therapeutic agents
are available, most notably multi-drug resistant myo-
bacterium tuberculosis, many viruses and prions. The
development and use of vaccines has similarly faced
numerous hurdles. The majority of bacterial and viral
pathogens, as well as all fungi and parasites, are still
not preventable by vaccines. New vaccines—such as
hepatitis A and varicella vaccines—have been marketed
in recent years, although some have had to be with-
drawn shortly after introduction due to concerns over
their safety. The most recent example of this has been
the tetravalent rhesus–human reassortant rotavirus
vaccine.12 Even for time-tested vaccines, serious
adverse reactions are constantly being reported and
their safety is now being closely scrutinised.13
The high expectations of the public and the afore-
mentioned challenges call for new thinking in the
surveillance and control of emerging infectious dis-
eases. Early recognition of emerging infections is
based on a good surveillance system for infective
agents. Conventional human surveillance, however, is
restricted in the sense that by the time zoonotic or
environmental pathogens have caused a significant
amount of disease, preventive programmes could
already be too late, or only achievable at great cost.
Hence, veterinary and environmental surveillance are
crucial adjuncts to human surveillance in a comprehen-
sive surveillance programme. The 1997 outbreak of
avian influenza H5N1 infection aptly illustrates this
principle: it took 7 months and 18 human cases with
six deaths to accumulate enough scientific data to
justify the culling of all poultry in the territory. In
contrast, the implementation of a very stringent poultry
surveillance programme by the Department of Health,
Food and Environmental Hygiene, and the Agriculture,
Fisheries and Conservation Department enabled
poultry-to-human transmission of the avian influenza
H5N1 virus to be prevented at a very early stage in May
this year. Further refinements in surveillance and the
introduction of a monthly chicken-free day through-
out the territory are perhaps the most effective
alternatives to central slaughtering of all poultry.
Once an emerging infection is anticipated, the
success of subsequent prevention and control pro-
grammes require a strong political commitment
from the government and health authorities. Risk
assessment and management should be followed
promptly by the drafting of counter-measures. For
diseases with pandemic potential, a coordinated
international response (including stepping-up of
surveillance in other countries and enhancement of
vaccine production or drug supply where applicable)
must be initiated at an early stage. For the frontline
professionals, rapid communication and frequent
updates on the disease are possible through easily
accessible electronic media (eg the internet). A solid
scientific background on infectious diseases is
crucial to achieve the aforesaid goals. This requires
not only expertise in clinical infectious diseases,
but also strong research in basic science. The latter is
especially important for newly discovered pathogens
or organisms for which no satisfactory diagnostic
tests are available. In the 1997 outbreak of avian
influenza H5N1 infection, the timely application of
molecular techniques, for example, enabled a poly-
merase chain reaction to be designed within 2 weeks
after the onset of the outbreak for rapid diagnosis of
H5N1 infections.7 The knowledge generated from
microbial genome projects will offer novel approaches
and opportunities in the control of infectious diseases
in the future.14
Infectious diseases traverse all boundaries—
biological and geographical—and Hong Kong has
witnessed many pandemic threats over the past 110
years. A stronger and more cohesive effort among all
parties—including medical professionals and the
public—is needed before the next wave of emerging
infectious diseases appears.
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